10X Genomics, Inc. Reagents for the Critical Care Medicine Department (CCMD)
Closed Pre-Solicitation Posted
- Solicitation number
- 25-003743
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) Clinical Center's Critical Care Medicine Department (CCMD) intends to award a firm fixed price Purchase Order to 10X Genomics, Inc. for specialized reagents supporting the Early Detection of Lung Diseases (EDLI) research project. The procurement will utilize Simplified Acquisition Procedures under FAR Part 13, which allows for sole source procurement when only one source is reasonably available. The specific reagents include Chromium Single Cell Human BCR and TCR Amplification Kits, Library Construction Kits, Chromium Next GEM Chip K Single Cell Kit, and Chromium Next GEM Single Cell 5' Kit v2. These proprietary reagents are critical for high-resolution gene expression profiling and immune repertoire analysis, with the unique capability to enable advanced molecular research into infectious and noninfectious lung diseases. Interested parties may submit comments or alternative capabilities to Tasha Lowe at lowet2@mail.nih.gov by February 20, 2025, at 3:00 PM, though the government retains sole discretion over competition determination.
The pre-solicitation notice indicates no specific set-aside for this procurement, and the contract is explicitly targeted to 10X Genomics, Inc. in Pleasanton, California. The procurement involves five distinct reagent kits, with quantities ranging from one to two units per kit type, totaling six units overall. While no specific award value is disclosed, the procurement is being conducted using Simplified Acquisition Procedures, which typically suggests a lower-value contract below the Simplified Acquisition Threshold. The place of performance is identified as Bethesda, MD 20892, and the procurement is categorized under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing. The solicitation emphasizes that only 10X Genomics reagents can be used with the existing CCMD instrumentation to ensure research integrity and prevent potential equipment damage or incorrect test outcomes.
Notice text
10X Genomics, Inc. Reagents for the Critical Care Medicine Department (CCMD)
- Product Service Code: 6550
- NAICS Code: 325413
- Place of Performance: Bethesda, MD 20892
POTS: 25-003743
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department (CCMD) intends to award a firm fixed price Purchase Order to 10X Genomics, Inc, located in Pleasanton, California 94588-3260 on a sole source basis to provide 10X Genomics Reagents.
The Critical Care Medicine Department is currently engaged in a project focused on the Early Detection of Lung Diseases (EDLI). The 10X Genomics Chromium 5' v2 Kit enables high-resolution gene expression profiling, immune repertoire analysis, and other advanced applications essential for identifying early biomarkers and understanding the molecular mechanisms behind both infectious and noninfectious lung diseases. The benefits of this technology have been consistently validated through multiple studies. To ensure accurate results, only proprietary reagents, consumables, and components from 10X Genomics, Inc. should be used with the existing instrumentation located within CCMD. Using incompatible reagents may damage the equipment and lead to incorrect test outcomes. To ensure the continuity and integrity of the research project, it is crucial to procure 10X Genomics reagents to support patient care.
Description/Product Code/Quantity:
Chromium Single Cell Human BCR Amplification Kit, 16 rxns/Product code: 1000253 Qty: 1
Chromium Single Cell Human TCR Amplification Kit, 16 rxns/Product code: 1000252 Qty: 1
Library Construction Kit, 16 rxns/Product Code: 1000190 Qty: 2
Chromium Next GEM Chip K Single Cell Kit, 48 rxns/Product Code:1000286 Qty: 1
Chromium™ Next GEM Single Cell 5' Kit v2, 16 rxns/ Product Code: 1000263 Qty: 1
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe, Contract Specialist, lowet2@mail.nih.gov by the due date February 20, 2025 and 3PM time marked in this notice
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| Combined Synopsis Solicitation- Acquire Flow Cytom | Office of Logisitics and Acquisition Operations | No set-aside | |
| RNA sequencing and whole genome sequencing services | Office of Logisitics and Acquisition Operations | No set-aside | |
| CSS - Upgrading PExA 2.1 to Vial-Based (PExA Cap) | Office of Logisitics and Acquisition Operations | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity